PainReform Ltd. Ordinary Shares (PRFX)
PainReform Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for chronic pain conditions. The company utilizes novel proprietary drug delivery technologies to enhance the efficacy and safety of pain management therapies. PainReform's pipeline emphasizes non-opioid solutions aimed at providing long-lasting relief for patients with unmet needs in pain treatment.
Company News
PainReform Ltd. has acquired a majority equity stake in LayerBio, a biotechnology company developing a breakthrough non-opiate, non-steroidal drug delivery system for postoperative pain management in cataract surgery, targeting the $9B global market.
PainReform, a pharmaceutical company, has acquired DeepSolar, an AI-driven solar analytics platform, to expand into the clean energy sector and leverage DeepSolar's technology to optimize solar energy asset management.
Best high-volume penny stocks for your watchlist right now? Check these 4 out The post Highest Volume Penny Stocks to Watch Today? Check These 4 Out appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.